Skip to content
ExpreS2ion Biotechnologies

ExpreS2ion Biotechnologies

Innovative vaccines for a healthier world

  • Company
    • About us
    • Disease focus
    • AdaptVac
    • Investors & Partners
  • Platform
  • Pipeline
    • Overview
    • ES2B-C001
  • CRO
  • Media
    • Press releases
    • Events
    • Multimedia
    • Publications
  • Investors
  • Careers

THE 8TH I4ID 2024

  • Home
  • Events
  • THE 8TH I4ID 2024
THE 8TH I4ID 2024
THE 8TH I4ID 2024
favorite_border
  • iCal Export
  • Google Calendar
  • Outlook 365
  • Outlook Live
27 Nov
Until 28 Nov

THE 8TH I4ID 2024

27-28 November 2024, CSO Farshad Guirakhoo will represent ExpreS2ion at the 8th Immunotherapies & Innovations for Infectious Diseases (I4ID) congress in Lyon.

To schedule a meeting, please contact us via email on info@expreS2ionbio.com. More information is available on the I4ID 2024 website.

Post navigation

HC Andersen Capital Institutional Investor Seminar
Aktiespararna’s Stora Aktiedagen

Copyright 2010 - All Rights Reserved

R&D
ExpreS2ion Biotechnologies ApS:
CVR/VAT: DK32770487
Agern Allé 1
DK-2970 Hørsholm, Denmark
Contact:
info@expres2ionbio.com
+45 22 22 10 19

Holding Company
ExpreS2ion Biotech Holding AB:
Registration number: 559033-3729
c/o Mindpark
Rönnowsgatan 8C
SE-252 25 Helsingborg, Sweden

Investor relations:
investor@expres2ionbio.com
Partnering:
partnering@expres2ionbio.com
Reagents and kits:
sales@expres2ionbio.com

More info:
Privacy Policy
Terms & General Conditions
Legal Notice & Disclaimer

Copyright © 2026 ExpreS2ion Biotechnologies All rights reserved. Theme: Flash by ThemeGrill. Powered by WordPress
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.